Concepedia

Fumihiko Ichikawa

FI

Statistics

Publications

11

Citations

367

H-Index

11

Active since

1972

Affiliations

Chugai Pharma (United States)(Current)

SHOWA Medical University

The University of Osaka

Mochida Pharmaceutical (Japan)

The University of Tokyo

Fumihiko Ichikawa is an author at Chugai Pharma (United States) specializing in medicine, vitamin d metabolism, and vitamin d.

Publications per year

1972–2013

11

Publications

11

Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats

Hiroki Maruyama, Ken Ataka, Fumitake Gejyo et al. · Gene Therapy · 2001 · 76 citations

, , +10

Mouse primary osteoblasts express vitamin D3 25-hydroxylase mRNA and convert 1 alpha-hydroxyvitamin D3 into 1 alpha,25-dihydroxyvitamin D3.

Fumihiko Ichikawa, Katsuhiko Sato, M. Nanjo et al. · PubMed · 1995 · 65 citations

, , +10

Mouse primary osteoblasts express vitamin D3 25-hydroxylase mRNA and convert 1α-hydroxyvitamin D3 into 1α,25-dihydroxyvitamin D3

Fumihiko Ichikawa, Katsuhiko Sato, M. Nanjo et al. · Bone · 1995 · 55 citations

, , +12

Evidence for the uptake of a vitamin D analogue (OCT) by a human carcinoma and its effect of suppressing the transcription of parathyroid hormone-related peptide gene in vivo.

Koichi Endo, Fumihiko Ichikawa, Y. Uchiyama et al. · Journal of Biological Chemistry · 1994 · 34 citations · Full text

, , +17

Dexamethasone Enhancement of Betaglycan (TGF-β Type III Receptor) Gene Expression in Osteoblast-like Cells

Hiroko Nakayama, Fumihiko Ichikawa, Janet Andres et al. · Experimental Cell Research · 1994 · 32 citations

, , +12

1–5 of 11